2022 annual financial data
Relay Therapeutics 2022 Operating margin
Relay Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was -21,670.89%.
Operating income was -299,275,000 USD and net income was -290,509,000 USD.
Operating cash flow was -229,490,000 USD.
Get free Relay Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,381,000 USD
- Operating income
- -299,275,000 USD
- Net income
- -290,509,000 USD
- Operating cash flow
- -229,490,000 USD